Skip to main content
Livermore
Livermore
ZHEN

Citadel Advisors LLC

SEC CIK
0001423053
Latest filing
Sep 1, 2026

EVGN holding history

Evogene Ltd. in every 13F filed by Citadel Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

EVGN overviewAll 13F holders of EVGNFull Q2 2026 holdings

Shares (Q2 2026)
50,526
Value
$21.4K
% of portfolio
<0.1%
Quarters held
18
Since Q1 2021
Holdings of EVGN by Citadel Advisors LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202650,526$21.4K<0.1%+50,526NewHolders
Q1 20260$00.0%−88,764−100.0%Sold outHolders
Q4 202588,764$97.6K<0.1%+31,189+54.2%AddedHolders
Q3 202557,575$65.6K<0.1%+36,206+169.4%AddedHolders
Q2 202521,369$27.4K<0.1%+21,369NewHolders
Q1 20250$00.0%−15,891−100.0%Sold outHolders
Q4 202415,891$29.7K<0.1%+15,891NewHolders
Q3 20240$00.0%−2,371−100.0%Sold outConverted for a 1-for-10 splitHolders
Q2 202423,710$15.4K<0.1%−36,201−60.4%ReducedHolders
Q1 202459,911$44.3K<0.1%+3,191+5.6%AddedHolders
Q4 202356,720$47.6K<0.1%+29,232+106.3%AddedHolders
Q3 202327,488$16.1K<0.1%+15,391+127.2%AddedHolders
Q2 202312,097$12.9K<0.1%−44,830−78.7%ReducedHolders
Q1 202356,927$35.9K<0.1%−27,601−32.7%ReducedHolders
Q4 202284,528$59.2K<0.1%−12,175−12.6%ReducedHolders
Q3 202296,703$80.0K<0.1%+96,703NewHolders
Q2 20220$00.0%−15,244−100.0%Sold outHolders
Q1 202215,244$20.0K<0.1%−85,451−84.9%ReducedHolders
Q4 2021100,695$165.0K<0.1%+25,332+33.6%AddedHolders
Q3 202175,363$199.0K<0.1%−38,242−33.7%ReducedHolders
Q2 2021113,605$388.0K<0.1%−39,151−25.6%ReducedHolders
Q1 2021152,756$770.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.